INVOKAMET XR 50-500 MG TABLET

canagliflozin and metformin hydrochloride
$9.6775per EA

Strength

50; 500 mg/1; mg/1

NDC

50458094001

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

12/17/2025

Approval Type

New Drug (NDA)

FDA Application

NDA205879

On Market Since

9/20/2016

Pharmacological Classes

Biguanide
Biguanides
P-Glycoprotein Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+0.1%

1Y

+0.5%

3Y

+11.2%

5Y

+11.2%

All

+41.5%

Generic Alternatives

Save up to 1%

1 alternative • Same active ingredient